Cardiometabolic disease, a term encompassing a cluster of conditions that increase the risk of cardiovascular disease and metabolic disorders, represents a significant health challenge in today's society. This multifaceted group includes conditions such as obesity, type 2 diabetes, and hypertension, which collectively contribute to an elevated risk of heart disease and stroke. The intricate interplay between genetics, lifestyle factors, and environmental influences underscores the complexity of cardiometabolic diseases. Sedentary lifestyles, poor dietary choices, and genetic predispositions can contribute to the development and progression of these interconnected conditions. Early detection and comprehensive management strategies are crucial in mitigating the impact of cardiometabolic disease, emphasizing the importance of lifestyle modifications, medication adherence, and regular health screenings. Public health initiatives aimed at promoting awareness, education, and preventive measures play a pivotal role in addressing the rising prevalence of cardiometabolic disease and fostering a healthier population.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China